Comparative Effectiveness of a Peer-led O2 Infoline for Patients and Caregivers
NCT ID: NCT02098369
Last Updated: 2018-08-06
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
444 participants
INTERVENTIONAL
2015-04-30
2016-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Monitoring and Peer Support to Improve Treatment Adherence and Outcomes
NCT03446768
Effect of Educational Intervention in Patients With Low-Risk Chronic Obstructive Pulmonary Disease
NCT00932711
Development And Evaluation of An Adaptive Web-Based Intervention for COPD
NCT06770777
Effectiveness and Feasibility of Delivering an Education Program to Patients With an Acute Exacerbation of COPD
NCT02321215
COPD Resources, Education, and Activity Designed for You Study
NCT07125053
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Usual care
Written education material (basic)
Written education material (basic)
Education material on COPD distributed to all participants.
Proactive
Written education material (basic) Additional education material PELICAN-Proactive \[In addition to the usual care, participants will receive educational material and a proactive telephone peer coaching program (coaches call participants)\]
Written education material (basic)
Education material on COPD distributed to all participants.
Additional education material
Additional education material sent to participants in the proactive and reactive arms.
PELICAN-Proactive
In the proactive arm, calls will be initiated by the coach. The phone calls will involve educational and social support components. PELICAN is grounded on the social cognitive theory of behavior change and seeks to improve patient adherence by addressing patient self-efficacy and outcome expectancy.
Reactive
Written education material (basic) Additional education material PELICAN-Reactive \[In addition to the usual care, participants will receive educational material and a reactive telephone peer coaching program (participants call coaches)\]
Written education material (basic)
Education material on COPD distributed to all participants.
Additional education material
Additional education material sent to participants in the proactive and reactive arms.
PELICAN-Reactive
Participants allocated to the reactive PELICAN group will be offered the opportunity to access the COPD Foundation Infoline toll-free.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Written education material (basic)
Education material on COPD distributed to all participants.
Additional education material
Additional education material sent to participants in the proactive and reactive arms.
PELICAN-Proactive
In the proactive arm, calls will be initiated by the coach. The phone calls will involve educational and social support components. PELICAN is grounded on the social cognitive theory of behavior change and seeks to improve patient adherence by addressing patient self-efficacy and outcome expectancy.
PELICAN-Reactive
Participants allocated to the reactive PELICAN group will be offered the opportunity to access the COPD Foundation Infoline toll-free.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Physician diagnosis of COPD
3. Physician prescription for home O2 for 24hrs/day, 7 days/week
4. Willing to use home O2.
5. Working telephone number.
Exclusion Criteria
2. Discharge to home hospice or expected survival less than 6 months.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AlphaNet
UNKNOWN
Apria Healthcare
UNKNOWN
COPD Foundation
OTHER
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
OTHER
National Jewish Health
OTHER
Patient-Centered Outcomes Research Institute
OTHER
American Association for Respiratory Care
OTHER
University of Illinois at Chicago
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jerry Krishnan
Professor of Medicine and Public Health; Associate Vice Chancellor for Population Health Sciences
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jerry A Krishnan, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Illinois at Chicago
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Apria Healthcare
Lake Forest, California, United States
Los Angeles Biomedical Research Institute
Torrance, California, United States
National Jewish Health
Denver, Colorado, United States
AlphaNet
Miami, Florida, United States
COPD Foundation
Miami, Florida, United States
University of Illinois Hospital
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Prieto-Centurion V, Holm KE, Casaburi R, Porszasz J, Basu S, Bracken NE, Gallardo R 3rd, Gonzalez V, Illendula SD, Sandhaus RA, Sullivan JL, Walsh LJ, Gerald LB, Krishnan JA. A Hybrid Effectiveness/Implementation Clinical Trial of Adherence to Long-Term Oxygen Therapy for Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2023 Nov;20(11):1561-1570. doi: 10.1513/AnnalsATS.202302-104OC.
Related Links
Access external resources that provide additional context or updates about the study.
Patient-Centered Outcomes Research Institute (PCORI): Funding Award details
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PCORI-CE 1304-6490
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.